Compare SPCB & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPCB | LNSR |
|---|---|---|
| Founded | 1988 | 2004 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.2M | 69.1M |
| IPO Year | 2004 | 2005 |
| Metric | SPCB | LNSR |
|---|---|---|
| Price | $11.23 | $6.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 74.0K | ★ 113.6K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | $27.13 | $41.48 |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $7.07 | $5.06 |
| 52 Week High | $13.57 | $13.43 |
| Indicator | SPCB | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 56.18 |
| Support Level | $9.88 | $5.33 |
| Resistance Level | $12.54 | $6.34 |
| Average True Range (ATR) | 0.90 | 0.39 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 43.71 | 68.54 |
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.